L-CARNITINE AS A TREATMENT FOR RETT-SYNDROME

被引:16
作者
PLIOPLYS, AV [1 ]
KASNICKA, I [1 ]
机构
[1] UNIV ILLINOIS,DEPT NEUROL,CHICAGO,IL
关键词
D O I
10.1097/00007611-199312000-00021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 17-year-old girl with Rett syndrome, who was taking no other medications, was treated with L-carnitine (50 mg/kg/day). Within 2 months of initiation of treatment, she became much more alert, developed good eye contact, started reaching for objects with both hands, and answered simple questions with one or two words. L-carnitine was discontinued and within 1 week she lapsed into her pretreatment condition of lethargy with no interest in her environment, not reaching for objects, poor eye contact, and not speaking. One week after L-carnitine was resumed, she again became alert, started reaching for objects, and saying one or two words. Her serum carnitine levels (free and total) were within normal limits before and after L-carnitine treatment, but were higher while she was taking L-carnitine. Her serum ammonia was within normal limits prior to starting L-carnitine. L-carnitine appears to be an effective treatment for this girl with advanced Rett syndrome.
引用
收藏
页码:1411 / 1413
页数:3
相关论文
共 8 条
[1]   CARNITINE, VALPROATE, AND TOXICITY [J].
COULTER, DL .
JOURNAL OF CHILD NEUROLOGY, 1991, 6 (01) :7-14
[2]   ABNORMAL MITOCHONDRIA IN THE RETT SYNDROME [J].
EEGOLOFSSON, O ;
ALZUHAIR, AGH ;
TEEBI, AS ;
ALESSA, MMN .
BRAIN & DEVELOPMENT, 1988, 10 (04) :260-262
[3]   RETT SYNDROME - GENETIC CLUES BASED ON MITOCHONDRIAL CHANGES IN MUSCLE [J].
EEGOLOFSSON, O ;
ALZUHAIR, AGH ;
TEEBI, AS ;
ALESSA, MMN .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1989, 32 (01) :142-144
[4]  
PHILIPPART M, 1988, Neurology, V38, P294
[5]  
PHILIPPART M, 1989, Neurology, V39, P156
[6]  
Rett A, 1966, Wien Med Wochenschr, V116, P723
[7]   RETT SYNDROME - FINDINGS SUGGESTING AXONOPATHY AND MITOCHONDRIAL ABNORMALITIES [J].
WAKAI, S ;
KAMEDA, K ;
ISHIKAWA, Y ;
MIYAMOTO, S ;
NAGAOKA, M ;
OKABE, M ;
MINAMI, R ;
TACHI, N .
PEDIATRIC NEUROLOGY, 1990, 6 (05) :339-343
[8]  
1988, ANN NEUROL, V23, P425